Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting

Seoul National University

Status: Unknown

Conditions: Coronary Artery Disease

Treatments: Device: Cypher; Device: Xience/Promus

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00960648

EXCELLENT-REGISTRY

Details and patient eligibility

About

The objective of this study is to evaluate the safety and long-term effectiveness of coronary stenting with the everolimus-eluting stent (EES) and to determine clinical device and procedural success during commercial use of EES in the real world.

The investigators will compare EES (Xience/Promus, prospective arm) with sirolimus-eluting stent (SES, Cypher, retrospective arm).

Enrollment: 4,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient agrees to participate in this study by signing the informed consent form.
• Alternatively, a legally authorized patient representative may agree to the patient's participation in this study and sign the informed consent form.

Exclusion criteria

• There are no exclusion criteria for this registry.

Trial design

4,000 participants in 2 patient groups

Xience/Promus

Description:

Active prospective registration of patients receiving everolimus eluting stent

Treatment:

Device: Xience/Promus

Cypher

Description:

Retrospective historical controls that received sirolimus-eluting stent

Treatment:

Device: Cypher